American journal of cancer research最新文献

{"title":"Risk factors for mediastinal lymph node metastases in early-stage non-small-cell lung cancer and prediction model establishment.","authors":"Yubo Tang, A Garu, Xiao Chen, Ziyun Guan, Xingdong Cai, Huaxing Huang, Linghu Xitao, Kejing Tang, Yong Dong","doi":"10.62347/DIZG4944","DOIUrl":"10.62347/DIZG4944","url":null,"abstract":"<p><p>This study aimed to explore the risk factors for mediastinal lymph node metastases (MLNM) in patients with early-stage non-small-cell lung cancer (NSCLC) and to establish a predictive model. A retrospective analysis was conducted on the clinical data from NSCLC patients treated at the Second Affiliated Hospital of Guangzhou Medical University and the First Affiliated Dongguan Hospital of Guangdong Medical University between March 2021 and March 2023. Baseline clinical data, laboratory parameters, and pathological features were collected and analyzed. Univariate and multivariate logistic regression identified several independent risk factors for MLNM, including Cyfra21-1, D-dimer (D-D), tumor size, percentage of tumor solid, and lesion location. These risk factors were incorporated into a Nomogram model to visually assess the likelihood of MLNM. The model demonstrated excellent diagnostic accuracy with an area under the curve (AUC) of 0.904, a specificity of 73.85%, and a sensitivity of 93.68%. Cyfra21-1 and D-D were particularly significant predictors of MLNM. This Nomogram model provides an effective and practical tool for assessing MLNM risk in early-stage NSCLC, aiding clinical decision-making and optimizing treatment strategies.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5952-5964"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142968845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Construction and evaluation of a multifactorial clinical model for discriminating benign and malignant breast tumors using LASSO algorithm based on retrospective cohort study.","authors":"Wenting Cui, Ying Wu, Yuewei Guo, Wei Li, Chen Huang, Yiqun Xie","doi":"10.62347/ILIJ7959","DOIUrl":"10.62347/ILIJ7959","url":null,"abstract":"<p><p>Breast cancer is one of the malignant tumors that seriously threaten women's health, and early diagnosis and detection of breast cancer are crucial for effective treatment. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is an important diagnostic tool that allows for the dynamic observation of blood flow characteristics of breast tumors, including small lesions within the affected tissue. Currently, it is widely used in clinical practice and has been shown promising prospects. This study included a total of 1,987 patients who underwent breast surgery at Huangpu Branch, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine from January 1, 2019 to December 31, 2019. Comprehensive patient information was collected, including ultrasound, mammography findings, physical examination details, age, family history, and pathological diagnoses. The least absolute shrinkage and selection operator (LASSO) algorithm was employed to assign values to the x variables, facilitating the construction and validation of the LASSO model group. Receiver operating characteristic curves were generated using support vector machines to determine the area under the curve (AUC), as well as to assess sensitivity and specificity. There were no statistically significant differences (P>0.05) in average age, body mass index, tumor location, or tumor benignity/malignancy between the training and test sets. The AUC, sensitivity, and specificity of mammography for predicting the benignity or malignancy of breast tumors were 0.83, 86.96%, and 76%, respectively. In comparison, the AUC, sensitivity, and specificity of DCE-MRI for the same predictions were 0.91, 91.3%, and 88%, respectively. The predictive performance of DCE-MRI was significantly higher than that of mammography (P<0.05). In conclusion, both mammography and DCE-MRI demonstrated high AUC, sensitivity, and specificity in predicting the benignity or malignancy of breast tumors. However, DCE-MRI showed superior predictive performance, making it a valuable tool for the early detection of clinical breast cancer with potential for broader clinical application.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5628-5643"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711528/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Deep learning to optimize radiotherapy decisions for elderly patients with early-stage breast cancer: a novel approach for personalized treatment.","authors":"Guangliang Yang, Haiqi Chen, Jinchao Yue","doi":"10.62347/TRNO3190","DOIUrl":"10.62347/TRNO3190","url":null,"abstract":"<p><p>The use of routine adjuvant radiotherapy (RT) after breast-conserving surgery (BCS) is controversial in elderly patients with early-stage breast cancer (EBC). This study aimed to evaluate the efficacy of adjuvant RT for elderly EBC patients using deep learning (DL) to personalize treatment plans. Five distinct DL models were developed to generate personalized treatment recommendations. Patients whose actual treatments aligned with the DL model suggestions were classified into the Consistent group, while those with divergent treatments were placed in the Inconsistent group. The efficacy of these models was assessed by comparing outcomes between the two groups. Multivariate logistic regression and Poisson regression analyses were used to visualize and quantify the influence of various features on adjuvant RT selection. In a cohort of 8,047 elderly EBC patients, treatment following the Deep Survival Regression with Mixture Effects (DSME) model's recommendations significantly improved survival, with inverse probability of treatment weighting (IPTW)-adjusted benefits, including a hazard ratio of 0.70 (95% CI, 0.58-0.86), a risk difference of 4.63% (95% CI, 1.59-7.66), and an extended mean survival time of 8.96 months (95% CI, 6.85-10.97), outperforming other models and the National Comprehensive Cancer Network (NCCN) guidelines. The DSME model identified elderly patients with larger tumors and more advanced disease stages as ideal candidates for adjuvant RT, though no benefit was seen in patients not recommended for it. This study introduces a novel DL-guided approach for selecting adjuvant RT in elderly EBC patients, enhancing treatment precision and potentially improving survival outcomes while minimizing unnecessary interventions.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5885-5896"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"XGBoost-based nomogram for predicting lymph node metastasis in endometrial carcinoma.","authors":"Xiaoting Lin, Fumin Gao, Haijiao Lin, Wang Yao, Yuxia Wang","doi":"10.62347/JVRG8195","DOIUrl":"10.62347/JVRG8195","url":null,"abstract":"<p><p>This study aims to construct and optimize risk prediction models for lymph node metastasis (LNM) in endometrial carcinoma (EC) patients, thus improving the identification of patients at high risk of LNM and further providing accurate support for clinical decision-making. This retrospective analysis included 541 cases of EC treated at The First Affiliated Hospital, Jinan University between January 2017 and January 2022. Various clinical and pathological variables were incorporated, including age, body mass index (BMI), pathological grading, myometrial invasion, lymphovascular space invasion (LVSI), estrogen receptor (ER) and progesterone receptor (PR) levels, and tumor size. Multivariate Logistic regression analysis was used to identify independent risk factors for LNM. Subsequently, the Least Absolute Shrinkage and Selection Operator (LASSO), Extreme Gradient Boosting (XGBoost), RandomForest, and Support Vector Machine (SVM), all machine-learning algorithms, were adopted to select features and build models. The XGBoost model gave the best performance among all models, with areas under the curve (AUCs) of 0.876 and 0.832 for training and validation sets, respectively, suggesting its high discriminatory ability and prediction accuracy. Moreover, the calibration curve analysis further verified the consistency of the model-predicted values with the actual results, indicating the model's good applicability at various risk levels. According to the decision curve analysis, the XGBoost model showed high net benefits within most risk-threshold ranges, indicating its substantial practical value in clinical applications. Conclusively, this study successfully builds machine-learning models based on multiple clinical and pathological features, which can effectively predict the LNM risk in EC patients. The model is expected to provide important references for clinicians in surgical decision-making and the formulation of individualized treatment plans, thereby enhancing patient outcomes.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5769-5783"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Predictive value of peripheral blood indicators plus procalcitonin clearance rate for mortality in cancer patients with sepsis.","authors":"Ting Zhu, Biao Tian, Lei Wang","doi":"10.62347/NKOL2327","DOIUrl":"10.62347/NKOL2327","url":null,"abstract":"<p><p>This study investigated the predictive value of combining peripheral blood indicators with procalcitonin clearance rate (PCTc) to assess mortality risk in cancer patients with sepsis, aiming to develop a more sensitive and specific clinical tool. A retrospective analysis was conducted on 393 cancer patients with sepsis admitted to South China Hospital of Shenzhen University from January 2019 to January 2024. Collected data included clinical demographics, laboratory indicators such as white blood cell count, neutrophil count (NEUT), platelet count (PLT), lymphocyte count (LYC), C-reactive protein, procalcitonin (PCT), alanine aminotransferase, and the ratio of arterial oxygen partial pressure to inspired oxygen fraction, as well as functional scores like Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment. Multivariate logistic regression and receiver operating characteristic curves assessed the predictive ability of these factors for 28-day survival. Results showed significantly higher NEUT (P<0.001) and lower PLT and LYC (P<0.001) in the death group, while APACHE II score (area under the curve (AUC) = 0.776) and PCT 24h (AUC = 0.723) demonstrated strong predictive value for mortality risk. The joint projection model's AUC reached 0.966, significantly outperforming individual indicators, indicating that combining multiple indicators offers a more accurate prediction of survival versus mortality risk. Additionally, 24h LCR and 24h PCTc were notably lower in the death group compared to the survival group, reinforcing the advantage of combined indicators for prognosis. Overall, using both peripheral blood indicators and PCTc significantly improves the accuracy of mortality risk assessment in cancer patients with sepsis, enhancing prognostic evaluation and supporting optimized clinical decision-making.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5839-5850"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711536/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Interaction of breast cancer-relevant DNA repair genes and air pollution in relation to breast cancer risk in UK biobank.","authors":"Carmen Smotherman, Brian Sprague, Dejana Braithwaite, Lusine Yaghjyan","doi":"10.62347/WNIY6250","DOIUrl":"10.62347/WNIY6250","url":null,"abstract":"<p><p>We investigated if selected polymorphisms in DNA repair genes modify the association between exposure to particulate matter ≤ 10 micron in diameter (PM₁₀) and breast cancer (BCa) risk. We included 150,929 postmenopausal women (5,969 with BCa) from UK Biobank, a population-based prospective cohort. Cancer diagnoses were ascertained through the linkage to the UK National Health Service Central Registers. Information on BCa risk factors was collected at baseline. Blood samples were collected from participants at enrollment and genotyped using the Applied Biosystems UK BiLEVE Axiom Array or the Applied Biosystems UK Biobank Axiom Array. Cox proportional hazards regression was used to examine interactions of exposure (2007 PM₁₀ and cumulative average PM₁₀) with 14 SNPs, adjusting for BCa risk factors. The positive associations of 2007 PM₁₀ and cumulative average PM₁₀ with BCa risk were stronger in women with one or two copies of XRCC2 rs3218536 C allele vs. none (2007 PM₁₀ Hazard Ratio [HR] per 10 µg/m³ = 1.54, 95% Confidence Interval [CI] 1.22, 1.95 or HR = 1.14, 95% CI 1.03, 1.30 vs. HR = 0.52, 95% CI 0.16, 1.75, p-interaction = 0.02; cumulative average PM₁₀ HR per 10 µg/m³ = 2.80, 95% CI 1.99, 3.96 or HR = 1.89, 95% CI 1.64, 2.18 vs. HR = 0.45, 95% CI 0.08, 2.37, p-interaction = 0.05). We observed no interactions of PM₁₀ with other SNPs. Our results suggest stronger associations of 2007 PM₁₀ and cumulative average PM₁₀ with postmenopausal BCa risk in carriers of XRCC2 rs3218536 C allele.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5935-5951"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"miR-542-3p/PIK3R1 axis is involved in hsa_circ_0087104-mediated inhibition of esophageal squamous cell carcinoma metastasis.","authors":"Shan Gao, Weiyang Lou","doi":"10.62347/EFEO7205","DOIUrl":"10.62347/EFEO7205","url":null,"abstract":"<p><p>Esophageal squamous cell carcinoma (ESCC), the most predominant subtype of esophageal cancer, is notorious for its high lymph node metastatic potential and poor prognosis. Growing evidence has demonstrated crucial function of circRNAs in human malignancies. However, the knowledge of circRNAs in lymph node metastasis of ESCC is still inadequate. In this study, a series of bioinformatic analyses and experimental validation were performed. By performing differential expression analysis and selection for GEO dataset GSE150476, a total of 8 circRNAs associated with lymph node metastasis of ESCC were identified. Expression analysis confirmed their low expression in ESCC tissues (relative to normal tissues) or metastatic sites (relative to primary sites). By combination of binding miRNAs from CSCD and starBase databases, six potential miRNAs (miR-532-5p, miR-2681-5p, miR-670-5p, miR-1252-5p, miR-382-3p and miR-542-3p) were predicted and a circRNA-miRNA regulatory network was constructed. Next, 695 target genes were predicted to bind to the 6 miRNAs. After conducting protein-protein interaction (PPI) network analysis, hub gene identification and expression analysis, a hub gene PIK3R1 was identified as the most potential downstream target gene of hsa_circ_0087104/miR-542-3p in ESCC. Hsa_circ_0087104 and PIK3R1 were decreased while miR-542-3p was increased in ESCC cells compared with normal esophageal epithelial cell line. Luciferase reporter and MS2-RIP assays confirmed the direct bind of miR-542-3p to hsa_circ_0087104 or PIK3R1. Hsa_circ_0087104 increased PIK3R1 expression but ectopic expression of miR-542-3p reversed hsa_circ_0087104-mediated PIK3R1 overexpression in ESCC. Overexpression of hsa_circ_0087104 suppressed <i>in vitro</i> migration and invasion of ESCC cells and this suppressive effect could be weakened by upregulation of miR-542-3p. Collectively, the current findings elucidated a potential hsa_circ_0087104/miR-542-3p/PIK3R1 axis that might be involved in suppression of lymph node metastasis of ESCC.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5665-5679"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711534/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endoscopic submucosal dissection for superficial ultra-low rectal tumors: outcomes and predictive factors for procedure difficulty.","authors":"Yinxin Wu, Yanqin Xu, Haiyan Lin, Xiaolu Lin, Wanyin Deng, Wei Liang, Qing Lin","doi":"10.62347/PVVD6843","DOIUrl":"10.62347/PVVD6843","url":null,"abstract":"<p><strong>Background: </strong>Ultra-low rectal endoscopic submucosal dissection (ESD) presents technical challenges due to anatomical features. The objective of this research was to determine the risk factors linked to unsuccessful curative resections and to create a nomogram predictive model to assess the likelihood of encountering technical challenges.</p><p><strong>Methods: </strong>Patients with ultra-low rectal tumors received ESD form June 2017 to December 2022 were retrospectively enrolled. An ESD procedure exceeding 30 min was deemed difficult. A logistic regression analysis was performed to pinpoint important factors and predictors. The effectiveness of the nomogram, which incorporated the identified predictors, was evaluated by employing receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA).</p><p><strong>Results: </strong>A total of 300 patients with ultra-low rectal tumors were enrolled, with a curative resection rate of 82.0%. Multivariate logistic regression revealed that poor lifting sign (OR = 3.282, <i>P</i> = 0.026), non-granular type laterally spreading tumors (LST-NG, OR = 2.230, <i>P</i> = 0.042) and procedure time ≥ 60 min (OR = 6.976, <i>P</i> = 0.010) contributed to non-curative resection. Predictors for ESD difficulty included tumor diameter ≥ 30 mm (compared with < 30 mm, 30-50 mm, OR = 2.450, <i>P</i> = 0.044; ≥ 50 mm, OR = 5.047, <i>P</i> = 0.009), ≥ 1/2 circumference involvement (OR = 3.183, <i>P</i> = 0.038); dentate line invasion (OR = 3.881, <i>P</i> = 0.026) and less colorectal ESD experience (OR = 3.415, <i>P</i> = 0.032). The nomogram performed well in both train and validation sets (area under the curve (AUC) = 0.873 and 0.810, respectively). Calibration plots exhibited satisfactory agreement between predicted and observed outcomes, and DCA showed superior clinical benefit of the model than individual predictors.</p><p><strong>Conclusions: </strong>Poor lifting sign, LST-NG and procedure time ≥ 60 min were associated with non-curative resection for ultra-low rectal ESD. By including factors such as tumor size, location, and the operator's experience with ESD, the nomogram can predict the complexity of the procedure before surgery.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5784-5797"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Peptidoglycan induces CXCL10 production and inhibits esophageal squamous cell carcinoma proliferation.","authors":"Yoshihiro Sasaki, Yusuke Sato, Kyoko Nomura, Akiyuki Wakita, Yushi Nagaki, Ryohei Sasamori, Takatoshi Yoneya, Tsukasa Takahashi, Munehiro Yamada, Mayu Takahashi, Kaori Terata, Kazuhiro Imai","doi":"10.62347/NHPV3701","DOIUrl":"10.62347/NHPV3701","url":null,"abstract":"<p><p>Poor oral health is an independent risk factor for upper-aerodigestive tract cancers, including esophageal squamous cell carcinoma (ESCC); thus, good oral health may reduce the risk of ESCC. We previously reported that high expression of Toll-like receptor (TLR) 6, which recognizes peptidoglycan (PGN) from Gram-positive bacteria correlates with a good prognosis after esophagectomy for ESCC. Most beneficial bacteria in the mouth are Gram-positive. We therefore hypothesized that PGN affects cancer cell proliferation and disease progression in ESCC. To test that idea, we assessed the expression of cytokine and chemokine mRNA and protein in eight ESCC cell lines. We also employed a mouse xenograft model to investigate the effect of PGN on ESCC tumor progression <i>in vivo</i>. We then investigated the relationship between the combined expression profiles of TLR6 and C-X-C motif chemokine ligand 10 (CXCL10) in clinical samples and 5-year overall survival (OS) and disease-specific survival (DSS) in ESCC patients after curative esophagectomy. We found that PGN significantly inhibited cell proliferation in six of eight ESCC lines and upregulated CXCL10 production via NF-κB2. <i>In vivo</i>, subcutaneous PGN administration tended to decrease ESCC tumor volume in mice. Combined high expression of TLR6 and CXCL10 correlated with a better prognosis in ESCC patients. This suggests that PGN reduces cell proliferation and tumor progression through a PGN-TLR-CXCL10 cascade, thereby influencing prognosis after esophagectomy for ESCC, and that improving the oral environment could potentially improve the prognosis of ESCC patients after esophagectomy.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5874-5884"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of upfront primary tumor resection in patients with synchronous <i>RAS</i> wild-type metastatic colorectal cancer.","authors":"Po-Jung Chen, Chou-Chen Chen, Shih-Ching Chang, Yu-Yao Chang, Bo-Wen Lin, Hong-Hwa Chen, Yao-Yu Hsieh, Hung-Chih Hsu, Meng-Che Hsieh, Tao-Wei Ke, Feng-Che Kuan, Chih-Chien Wu, Wei-Chen Lu, Yu-Li Su, Yi-Hsin Liang, Joe-Bin Chen, Shuan-Yuan Huang, Ching-Wen Huang, Jaw-Yuan Wang","doi":"10.62347/DLWI1455","DOIUrl":"10.62347/DLWI1455","url":null,"abstract":"<p><p>This multicenter study explored the survival benefits of upfront primary tumor resection (PTR) followed by first-line cetuximab plus chemotherapy in real-world patients with <i>RAS</i> wild-type metastatic colorectal cancer (mCRC). Treatment options for mCRC include chemotherapy, targeted therapy, immunotherapy, and surgery. The efficacy of upfront PTR in managing mCRC remains unclear. In this retrospective study, we evaluated the outcomes of upfront PTR in 582 patients with synchronous <i>RAS</i> wild-type mCRC who received cetuximab plus chemotherapy as first-line treatment between November 2016 and August 2020. Of these patients, 364 (62.5%) underwent upfront PTR (PTR group) and 218 (37.5%) did not (non-PTR group). Relevant data were collected from 14 medical institutions in Taiwan. No significant differences were discovered between the PTR and non-PTR groups in median overall survival (37.9 vs. 31.7 months; <i>P</i> = 0.079) or progression-free survival (13.70 vs. 13.29 months; <i>P</i> = 0.62). Compared with patients who did not undergo metastasectomy, those who underwent this surgery exhibited significantly longer median overall survival (29.2 vs. 54.18 months; <i>P</i> < 0.001) and progression-free survival (12.8 vs. 15.60 months; <i>P</i> = 0.013). Our findings suggest that upfront PTR may not improve oncological outcomes in patients with synchronous <i>RAS</i> wild-type mCRC. Cetuximab-based targeted therapy plus chemotherapy appears to be suitable as first-line treatment for these patients. This study indicates that upfront PTR should be considered only for patients exhibiting symptoms such as tumor bleeding, perforation, or obstruction.</p>","PeriodicalId":7437,"journal":{"name":"American journal of cancer research","volume":"14 12","pages":"5863-5873"},"PeriodicalIF":3.6,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11711521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}